Utility of Comprehensive Cancer Genome Profiling Testing in Elderly Cancer Patients

There was no difference in the rate of access to insurance-approved drugs or clinical trials between elderly and non-elderly cancer patients, which suggests that CGP testing is also useful in elderly patients. More effective drugs may help reduce unnecessary toxicity. As elderly patients may be at higher risk of being unable to receive treatment due to deterioration of their general condition, CGP testing should be performed early.